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Microcytosis, with or without red cell hypochromia, 
is a common abnormality detected in a full 
blood count (FBC) and often prompts clinicians 
to investigate further for a cause. The differential 
diagnosis of microcytic and hypochromic red cell 
indices includes iron deficiency anaemia, anaemia of chronic disease, 
α- or β-thalassaemia trait, and sideroblastic anaemia. In the absence 
of iron deficiency and chronic disease, clinicians often request a 
haemoglobinopathy screen to exclude thalassaemia.
Whereas heterozygous β-thalassaemia is readily identified 
through an increased haemoglobin (Hb)A2 level using Hb separation 
techniques, without DNA analysis α-thalassaemia trait remains a 
diagnosis of exclusion. Although HbH inclusions are occasionally 
observed on incubated reticulocyte preparations in two-gene 
deletion α-thalassaemia, the majority of α-thalassaemia traits remain 
undetected through routine laboratory methods.
In a quest to distinguish iron deficiency from thalassaemia trait, 
several formulae utilising red cell indices from a routine FBC have 
been proposed.[1] These serve as good screening tools, but are unable 
to distinguish between α- and β-thalassaemia.
Since definitive exclusion of α-thalassaemia can only be obtained 
through molecular characterisation of the α-globin gene, the most 
logical diagnostic approach for unexplained microcytosis would be to 
use polymerase chain reaction (PCR) analysis to detect the common 
α-globin gene deletions. In this study we employed a multiplex PCR 
assay designed to detect the seven most common α-thalassaemia 
deletions.[2,3]
Methods
Patients and controls
Patient samples were selected from routine specimens received for 
FBC analysis at the Chris Hani Baragwanath Academic, Charlotte 
Maxeke Johannesburg Academic and Helen Joseph Hospital 
laboratories in Johannesburg, South Africa. A total of 100 patient 
samples were collected over a period of 36 months, of which 86 
fulfilled the criteria for unexplained microcytosis, as defined below.
Inclusion criteria
Inclusion criteria were: (i) microcytosis with a mean cell volume 
(MCV) <81 fl; (ii) mean cell haemoglobin (MCH) <27 pg; (iii) 
normal/borderline serum iron studies (ferritin 30 - 400 µg/L (male), 
15 - 150 µg/L (female), and serum iron 9 - 30 µmol/L); and (iv) 
normal/decreased HbA2 level (normal 2.4 - 3.7%).
Control samples (N=146) were obtained from volunteer staff 
members (aged >18 years). Those with normal FBCs and iron profiles 
were enlisted as controls. Among the 146 control subjects, 49 had 
microcytosis and were therefore excluded from the control group. 
Analysis
The following tests were performed on the control and patient 
groups:
1.   FBC and reticulocyte count (automated Sysmex XE 5000, analyser; 
Sysmex Incorporated, Japan), blood smears for microscopy 
(automated Sysmex 1000i slide maker and stainer; Sysmex 
Incorporated, Japan), and reticulocyte preparation for microscopy 
(2-hour incubation with 1% Brilliant Cresyl Blue supravital stain; 
National Health Laboratory Service, South Africa).
2.   Serum iron studies including serum iron, serum ferritin, serum 
transferrin and percentage saturation (Cobas analyser; Sysmex 
Incorporated, Japan) using the ferrozine method without 
deproteinisation for serum iron, and immunological agglutination 
principle for transferrin and ferritin). The percentage saturation 
was calculated using the serum iron and transferrin levels.
3.   Relative quantification of the Hb subtypes. This was obtained 
using cation exchange high-pressure liquid chromatography 
(HPLC) (Bio-Rad D10 analyser; Bio-Rad Laboratories, USA). 
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All abnormal results on HPLC were con-
firmed with alkaline and acid pH Hb 
electrophoresis (HYDRASYS system, 
Sebia-Norcross; SEBIA-INC, USA)
4.   Multiplex PCR was performed as des-
cribed by Chong et al.[3] DNA was extrac-
ted using a High Pure PCR preparation kit 
(Roche Diagnostics, Germany). 
Alpha-thalassaemia PCR 
methodology
On initial set-up the PCR reaction for 
each genotype was optimised individually 
(Table 1), and then adapted for all seven 
genotypes in a multiplex system with the 
respective sets of primers.
The volumes referred to in Table 1 are for 
a single PCR reaction. The conditions of the 
cycler were programmed as follows: PCR 
reaction initiated at 95°C for 10 minutes 
followed by 35 cycles, each comprising: 
(i) denaturation step → 45 seconds at 97°C; 
(ii) annealing step → 90 seconds at 61°C; 
and (iii) initial elongation step → 72°C 
for 90 seconds. A final elongation step 
then followed the 35 cycles at 72°C for 
5 minutes.
The deletions were detected through 
separation of the PCR products by electro-
phoresis on a 1.5% agarose gel (stained 
with ethidium bromide). The bands 
were visualised and photographed under 
ultraviolet transillumination, and identified 
using known controls (complements of AS 
Tan, Department of Paediatrics, National 
University of Singapore, and SL Thein, 
King’s College London Hospital, UK). A 
1 kb DNA marker was included in each run 
(Figs 1 and 2).
Statistical analysis
Statistical analysis was carried out using 
the Statistical Analysis System (SAS) 
program, version 9.1 (North Carolina State 
University, USA). The Wilcoxon two-sample 
test was used to analyse the haematological 
and biochemical parameters between the 
patient and control groups. Fisher’s exact test 
was used to calculate the frequency of the 
genotypes and the percentage differences in 
the population groups.
Results
All patients and control subjects were adults, 
with mean ages for the two groups of 34.5 
(standard deviation (SD) 14.5) and 36.4 
(SD 12.7) years, respectively. The gender 
split showed male/female ratios of 0.45 
and 0.46 in the patient and control groups, 
respectively. Ethnic groups were determined 
as per hospital classification. In the patient 
group, blacks, Indians and whites comprised 
51.1%, 40.7% and 8.1%, respectively. There 
were two subjects of mixed ancestry, who 
were incorporated into the black group for 
analysis. A similar distribution was noted in 
the control group, where blacks, Indians and 
whites comprised 54.6%, 28.8% and 16.4%, 
respectively.
Haematological parameters including Hb, 
MCV, MCH, RDW (red cell distribution 
width) and HbA2 were significantly lower in 
the patient group than in the control group 
(p<0.05) (Table 2).
Transferrin and ferritin levels showed no 
significant difference between the patient 
Table 1. PCR master mix for single-tube multiplex PCR of common α-thalassaemia 
deletions
Reagent 1 tube volume Final concentration
2 × Qiagen Master mix* 25 mL 1 × 1.5 mM MgCl2
Multiplex Primer mix 3.5 mL 10 mM
Bovine serum albumin 2.0 mL 20 mM
Q-Solution 7.5 mL
Sterile water 7.0 mL
For blank add purified water/patient or  
control DNA (100 ng/mL)
5.0 mL Not added to master mix
Total 50.0 mL
*Contains HotStarTaq DNA polymerase, multiplex PCR buffer, deoxynucleotides (dNTPs) mix and 1 mM MgCl2.
Table 2. Haematological results in patients and controls, mean (SD)
Parameter Patients (N=86) Controls (N=97) p-value
Hb (g/L) 12.9 (2.35) 14.3 (1.28) <0.0001
MCV (fl) 73.6 (7.06) 87.8 (4.53) <0.0001
MCH (pg) 23.8 (3.08) 30.3 (1.88) <0.0001
RDW 16.1 (4.13) 13.3 (0.89) <0.0001
HbA2 2.47 (0.63) 2.80 (0.67) 0.0027
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Fig. 1. PCR gel with known positive controls showing six common α-thalassaemia deletions including 
αα/––FIL deletion (lane 3).
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and control groups. Serum iron levels, 
however, displayed a statistically significant 
difference (p=0.0441) between patients 
and controls, but these values were within 
normal limits (>10 µmol/L).
Multiplex PCR for detecting the seven 
common deletional α-thalassaemia variants 
was performed in all patient and control 
subjects (Figs 1 and 2). Of a total of 86 in 
the patient group, 64 (78.0%) tested positive 
for α-thalassaemia. The prevalences in the 
black, Indian and white population groups 
were 80.0%, 85.3% and 37.5%, respectively. 
There were four indeterminate results, 
which were excluded from analysis. This 
left 18 subjects (22.0%) for whom the cause 
of the microcytosis remains unexplained 
(Table 3). Multiplex PCR analysis on control 
subjects yielded negative results.
The breakdown of the various α-thalass-
aemia genotypes encountered in the study 
group is detailed in Table 4. The most 
common α-thalassaemia genotype was –α3.7, 
which accounted for 92.1%, whereas the 
–α4.2 genotype accounted for 4.7% of the 
total number of positive results. In addition, 
two subjects had a double heterozygous 
genotype, viz.–α3.7/–α4.2 and –α3.7/––SEA.
The subject with the –α3.7/––SEA mutation was 
of Malaysian descent with HbH disease and 
was incorporated into the Indian group for 
analysis.
Hb separation revealed seven subjects 
with sickle cell disease, of whom five had 
α-thalassaemia on PCR.
Discussion
Red cell microcytosis and hypochromia 
are commonly encountered in the clinical 
setting. Differentiating between the causes of 
micro cytosis (with or without hypochromia) 
poses a challenge to clinicians. Not only does 
an accurate diagnosis allow for appropriate 
management and counselling, it also has 
therapeutic implications, particularly with 
regard to unnecessary iron therapy. Iron 
deficiency and chronic disorder remain the 
leading causes of microcytosis, followed by 
α-thalassaemia variants caused by deletion of 
α-globin gene/s, which is the most frequent 
haemoglobinopathy globally. [4] More than 40 
different deletional variants of α-thalassaemia 
have been described.[5] Globally, the majority 
of α-thalassaemia is caused by the seven 
deletions tested for in this study.[2]
Of 86 subjects in the patient group, 78.0% 
tested positive for α-thalassaemia PCR, 
which leaves 22.0% for whom the cause 
of the microcytosis remains unexplained. 
Possible reasons for a negative PCR result 
include: (i) the presence of α-thalassaemia 
deletions not tested for, such as the αα/––SA 
mutation,[6] and (ii) α-thalassaemia caused by 
non-deletional α-gene mutations, which are 
uncommon. Sequencing of α-globin genes 
would be necessary to detect non-deletional 
α-thalassaemia mutations, as these are not 
detected by Gap PCR.
The most common deletional variant in 
this study was the αα/–α3.7 genotype (92.1%). 
The prevalence of the αα/–α3.7 genotype was 
similar in the black and Indian groups, 
viz. 80.0% and 85.3%, respectively. Other 
α-thalasaemia genotypes were uncommon, 
with αα/–α4.2 and αα/––SEA constituting 4.7% 
and 1.6% (single case), respectively. The 
subject with the αα/––SEA deletion had HbH 
disease and HbH inclusions were detected 
on microscopy (incubated reticulocyte 
preparation) in >50% of the red cell popu-
lation. This finding is not surprising as 
the patient was of Malaysian descent, a 
population group in which the deletion is 
found in high frequencies.[7] Double α-globin 
deletions in cis (α0) were not encountered 
in black subjects in our study group. This 
finding is not unexpected since α0 deletions 
are rare in the black population, which also 
explains the rarity of HbH disease in this 
ethnic group.[8-9]
Table 3. Breakdown of positive, negative and indeterminate results in each population group
Population 
group
Total patient 
group, N
Positive 
PCR, n
Negative 
PCR, n
Indeterminate 
PCR, n
Black 42 32 8 2
Indian 36 29 5 2
White 8 3 5 0
Total 86 64 18 4
Table 4. Breakdown of positive, negative and indeterminate results in each population group
Population 
group Total positives, N αα/–α3.7, n αα/–α4.2, n –α3.7/–α4.2, n –α3.7/–αSEA, n
Black 32 30 1 1 -
Indian 29 26 2 - 1
White 3 3 - - -
Total 64 59 3 1 1
Lis 1 control
2503 bp
Lane 1. Lane 5.
Lane 2.
Lane 3.
Lane 4.
Lane 6.
Lane 7.
Lane 8.
 Blank.
–α3.7/– –SEA deletion
αα/– –SEA (control)
GeneRuler 100 bp Plus DNA
Ladder
αα/–α4.2 deletion
αα/–α3.7 deletion
–α3.7/–α4.2 deletion (control)
αα/αα negative (control)
1 2 3 4 5 6 7 8
Fig. 2. PCR gel showing –α3.7, –α4.2 and  –αSEA genotypes from the patient group.
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This pattern of alpha genotype distribution has been mirrored in 
other studies. Sankar et al.[10] reported the incidence of ––/α3.7 as the 
most common genotype (35.7%) in microcytic hypochromic subjects 
of Indian descent. In their study, other causes of  microcytosis such 
as iron deficiency and β-thalassaemia trait were not excluded from 
the cohort. A Canadian group[11] yielded a PCR-positive rate of only 
24.5% in their unexplained microcytosis cohort. In their study, only 
29% of the population were of Asian descent (immigrants), with the 
remainder being of Canadian descent. Of the positive PCR results, 
αα/–α3.7, αα/–α4.2, αα/–αSEA and αα/–αMED comprised 81.25%, 6.25%, 
10.4% and 2.0% of the total, respectively. In both the studies above, 
–α3.7 was the most common mutation as a cause for α-thalassaemia.
In our study, of the 49 subjects excluded from the control group, 
26 were confirmed to have iron deficiency and the remaining 23 
tested positive for α-globin gene deletion/s. In the unadjusted control 
population of 120 subjects (97 normal controls + 23 controls with 
α-thalassaemia on PCR analysis and excluded from the control 
group), the extrapolated incidence of α-thalassaemia in the normal 
population is calculated as 19.1%.
Two additional haemoglobin abnormalities were detected in the 
control group viz., heterozygous β-thalassaemia (in two subjects), 
and hereditary persistence of fetal haemoglin (HPFH) with an HbF 
level of 30% and pancellular distribution of HbF (in one subject).
In resource-poor settings, PCR analysis may prove prohibitive for 
routine testing. However, if the MCV were utilised as a screening 
tool, a significant percentage of cases would remain unsuspected 
and/or undetected, a scenario that is far from ideal, particularly 
for prenatal and premarital screening. Multiplex PCR would offer a 
cost-effective solution for the detection of α-globin gene deletions.
Conclusion
Unexplained microcytosis is a frequently encountered problem in 
clinical practice. In this study, α-globin gene deletions accounted 
for 78% of unexplained microcytosis. Twenty-two percent of cases 
remain unexplained, and further studies are warranted to explore the 
possibility of other genetic defects in the α-globin cluster.
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